J A Hank

447 total citations
7 papers, 343 citations indexed

About

J A Hank is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J A Hank has authored 7 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J A Hank's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). J A Hank is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). J A Hank collaborates with scholars based in United States and Cameroon. J A Hank's co-authors include Robin Bechhofer, Peter Köhler, Barry E. Storer, Jeff Sosman, Nancy S. Rosenthal, Paul M. Sondel, Paul M. Sondel, Kate H. Moore, G Weil-Hillman and J Bradshaw and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Immunotherapy and Clinical and Diagnostic Laboratory Immunology.

In The Last Decade

J A Hank

7 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J A Hank United States	7	256	180	53	39	33	7	343
Stefania Laurent Italy	7	284 1.1×	322 1.8×	65 1.2×	39 1.0×	14 0.4×	10	448
Ming Gu China	7	206 0.8×	250 1.4×	84 1.6×	22 0.6×	16 0.5×	12	381
Kieran Adam United States	11	191 0.7×	195 1.1×	73 1.4×	17 0.4×	6 0.2×	26	350
Roberta Gonella Italy	10	61 0.2×	115 0.6×	61 1.2×	27 0.7×	9 0.3×	17	257
Simanta Pathak United States	9	210 0.8×	86 0.5×	121 2.3×	23 0.6×	8 0.2×	12	371
Hiroto Sakoda Japan	9	128 0.5×	80 0.4×	44 0.8×	25 0.6×	10 0.3×	27	243
Manfred Ahlgrimm Germany	8	50 0.2×	90 0.5×	76 1.4×	27 0.7×	24 0.7×	17	272
Mikiya Ishihara Japan	8	100 0.4×	146 0.8×	65 1.2×	29 0.7×	9 0.3×	35	234
Mingzeng Zhang Japan	10	280 1.1×	50 0.3×	98 1.8×	38 1.0×	8 0.2×	15	410
Davide Bommarito United States	3	210 0.8×	248 1.4×	45 0.8×	10 0.3×	9 0.3×	6	335

Countries citing papers authored by J A Hank

Since Specialization

Citations

This map shows the geographic impact of J A Hank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Hank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Hank more than expected).

Fields of papers citing papers by J A Hank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Hank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Hank. The network helps show where J A Hank may publish in the future.

Co-authorship network of co-authors of J A Hank

This figure shows the co-authorship network connecting the top 25 collaborators of J A Hank. A scholar is included among the top collaborators of J A Hank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Hank. J A Hank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kendra, Kari, et al.. (1999). Specific Enzyme-Linked Immunosorbent Assays for Quantitation of Antibody-Cytokine Fusion Proteins. Clinical and Diagnostic Laboratory Immunology. 6(2). 236–242. 15 indexed citations

2.

Hank, J A, Jean E. Surfus, Mark R. Albertini, et al.. (1999). Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations.. PubMed. 5(2). 281–9. 23 indexed citations

3.

Hank, J A, Jean E. Surfus, Jing Gan, et al.. (1996). ACTIVATION OF HUMAN EFFECTOR CELLS BY A TUMOR REACTIVE RECOMBINANT ANTI-GANGLIOSIDE GD2 INTERLEUKIN-2 FUSION PROTEIN. Journal of Immunotherapy. 19(6). 463–463. 6 indexed citations

4.

Weil-Hillman, G, Stephan D. Voss, Paul Fisch, et al.. (1990). Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.. PubMed. 50(9). 2683–91. 27 indexed citations

5.

Sosman, Jeff, Peter Köhler, J A Hank, et al.. (1988). Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin. JNCI Journal of the National Cancer Institute. 80(18). 1451–1461. 75 indexed citations

6.

Sondel, Paul M., Peter Köhler, J A Hank, et al.. (1988). Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.. PubMed. 48(9). 2561–7. 132 indexed citations

7.

Hank, J A, Peter Köhler, G Weil-Hillman, et al.. (1988). In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.. PubMed. 48(7). 1965–71. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact